Ambien and Viibryd drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Ambien and Viibryd together. This study is created by eHealthMe based on reports of 277 people who take Ambien and Viibryd from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on zolpidem tartrate and vilazodone hydrochloride (the active ingredients of Ambien and Viibryd, respectively), and Ambien and Viibryd (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. (latest outcomes from Ambien 75,817 users)

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. (latest outcomes from Viibryd 6,874 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 16, 2019

277 people who take Ambien, Viibryd are studied.


Number of reports submitted per year:

Ambien and Viibryd drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Diarrhoea
  2. Arthralgia (joint pain)
  3. Headache (pain in head)
  4. Suicide attempt
  5. Completed suicide (act of taking one's own life)
  6. Intentional overdose
  7. Myalgia (muscle pain)
  8. Dizziness
  9. Muscle twitching
  10. Suicidal ideation
1 - 6 months:
  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Dizziness
  3. Drug level increased
  4. Flatulence (flatus expelled through the anus)
  5. Frequent bowel movements
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Groin pain
  8. Hot flush (sudden feelings of heat)
  9. Hypomania (a mild form of mania, marked by elation and hyperactivity)
  10. Increased appetite
6 - 12 months:
  1. Headache (pain in head)
  2. Arthralgia (joint pain)
  3. Arthropathy
  4. Diarrhoea
  5. Fall
  6. Gastric ph increased
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Infection
  9. Joint stiffness
  10. Lymphadenopathy (disease or enlargement of lymph nodes)
1 - 2 years:
  1. Fatigue (feeling of tiredness)
  2. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  3. Asthma
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Hospitalisation
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Memory impairment
  9. Nausea (feeling of having an urge to vomit)
  10. Pain
2 - 5 years:
  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Drug ineffective
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Gastric ph increased
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Headache (pain in head)
  8. Infection
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Post concussion syndrome
5 - 10 years:

n/a

10+ years:
  1. Parkinson's disease
  2. Headache (pain in head)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Pre-existing condition improved
  5. Productive cough
  6. Restless legs syndrome (a powerful urge to move your legs)
  7. Temporomandibular joint syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress)
  8. Therapeutic response unexpected
not specified:
  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Drug ineffective
  4. Fatigue (feeling of tiredness)
  5. Weight increased
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Asthenia (weakness)
  8. Headache (pain in head)
  9. Pain
  10. Gait disturbance

Most common drug interactions by gender *:

female:
  1. Intentional overdose
  2. Pruritus (severe itching of the skin)
  3. Pneumonia
  4. Dizziness
  5. Vomiting
  6. Dyspnoea (difficult or laboured respiration)
  7. Crying
  8. Loss of consciousness
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Throat tightness
male:
  1. Diarrhoea
  2. Arthralgia (joint pain)
  3. Drug ineffective
  4. Muscle twitching
  5. Arthropathy
  6. Joint stiffness
  7. Lymphadenopathy (disease or enlargement of lymph nodes)
  8. Nerve injury
  9. Night sweats (sweating in night)
  10. Asthenia (weakness)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:
  1. Completed suicide (act of taking one's own life)
  2. Intentional overdose
  3. Haemoglobin decreased
  4. Hepatitis (inflammation of the liver)
  5. Pain
  6. Abdominal pain upper
  7. Affect lability (emotional incontinence)
  8. Back injury
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Crying
30-39:
  1. Panic attack
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Drug ineffective
  4. Fatigue (feeling of tiredness)
  5. Suicidal ideation
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Headache (pain in head)
  8. Pain
  9. Pruritus (severe itching of the skin)
  10. Speech disorder
40-49:
  1. Suicide attempt
  2. Diarrhoea
  3. Gait disturbance
  4. Suicidal ideation
  5. Intentional overdose
  6. Asthenia (weakness)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Pruritus (severe itching of the skin)
  9. Dysarthria (speech disorder)
  10. Fatigue (feeling of tiredness)
50-59:
  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Migraine (headache)
  6. Pneumonia
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Throat tightness
  10. Vaginal haemorrhage (vaginal bleeding)
60+:
  1. Nausea (feeling of having an urge to vomit)
  2. Drug ineffective
  3. Cardiac failure congestive
  4. Decreased appetite
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Agitation (state of anxiety or nervous excitement)
  7. Weight increased
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Abdominal pain
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

* Approximation only. Some reports may have incomplete information.


Do you take Ambien and Viibryd?

You are not alone:




Related publications that referenced our studies


Results from eHealthMe (non-FDA) reports of taking Ambien and Viibryd together

Drug effectiveness (drug is found to be effective) over time *:
Ambien:
  • < 1 month: 0.0% (0 of 1 people)
  • 1 - 6 months: 50% (1 of 2 people)
  • 6 - 12 months: 33% (1 of 3 people)
  • 1 - 2 years: 0.0% (0 of 0 people)
  • 2 - 5 years: 50% (1 of 2 people)
  • 5 - 10 years: 50% (1 of 2 people)
  • 10+ years: 0.0% (0 of 0 people)
  • not specified: 0.0% (0 of 0 people)
Viibryd:
  • < 1 month: 0.0% (0 of 0 people)
  • 1 - 6 months: 16% (1 of 6 people)
  • 6 - 12 months: 100% (1 of 1 people)
  • 1 - 2 years: 100% (4 of 4 people)
  • 2 - 5 years: 0.0% (0 of 0 people)
  • 5 - 10 years: 0.0% (0 of 0 people)
  • 10+ years: 0.0% (0 of 0 people)
  • not specified: 0.0% (0 of 0 people)
Drug effectiveness (drug is found to be effective) by gender *:
Ambien:
  • female: 25% (2 of 8 people)
  • male: 100% (2 of 2 people)
Viibryd:
  • female: 66% (6 of 9 people)
  • male: 0.0% (0 of 2 people)
Drug effectiveness (drug is found to be effective) by age *:
Ambien:
  • 0-1: 0.0% (0 of 0 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 100.0% (1 of 1 people)
  • 30-39: 0.0% (0 of 2 people)
  • 40-49: 40.0% (2 of 5 people)
  • 50-59: 50.0% (1 of 2 people)
  • 60+: 0.0% (0 of 0 people)
Viibryd:
  • 0-1: 0.0% (0 of 0 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 100.0% (1 of 1 people)
  • 30-39: 100.0% (2 of 2 people)
  • 40-49: 60.0% (3 of 5 people)
  • 50-59: 0.0% (0 of 3 people)
  • 60+: 0.0% (0 of 0 people)
Race of the people *:
  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 0.0 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 0.0 %
  • White, Non-Hispanic: 100 %

* Approximation only.


Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Ambien and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Viibryd and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Ambien and Viibryd
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Ambien and Viibryd



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.